By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


SEARCH JOBS








Company News
Actinium (ATNM.OB) Granted Orphan Designation From The EMA For Actimab-A 5/24/2017 10:17:38 AM
Actinium (ATNM.OB) Announces Appointment Of Hematology Expert Dr. Richard Stone Of The Dana-Farber Cancer Institute To Its Scientific Advisory Board 5/17/2017 11:04:53 AM
Actinium (ATNM.OB) Receives Clearance From Health Canada To Initiate Pivotal Phase III SIERRA Trial Of Iomab-B 5/10/2017 8:14:25 AM
Actinium (ATNM.OB) Announces Sponsorship Of The Acute Leukemia Forum 2017 4/19/2017 1:06:14 PM
Actinium (ATNM.OB) Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., To The Company’s Board Of Directors 3/28/2017 12:58:44 PM
Actinium (ATNM.OB) Announces Receipt Of Positive Scientific Advice From The EMA For Iomab-B 3/21/2017 10:56:00 AM
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017 10:34:31 AM
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017 8:15:59 AM
Actinium (ATNM.OB) Announces Hiring Of Steven Price To Position Of Vice President, Clinical And Commercial Strategy 2/21/2017 10:50:18 AM
Actinium (ATNM.OB) To Present At BIO CEO & Investor Conference 2/9/2017 10:06:37 AM
12345678910...
//-->